Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Sep 2020 09:00 AM
RNS
Holding(s) in Company
15 Sep 2020 01:12 PM
RNS
Holding(s) in Company
14 Sep 2020 04:40 PM
RNS
Second Price Monitoring Extn
14 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
14 Sep 2020 07:00 AM
RNS
Holding(s) in Company
04 Aug 2020 02:05 PM
RNS
Second Price Monitoring Extn
04 Aug 2020 02:00 PM
RNS
Price Monitoring Extension
04 Aug 2020 07:00 AM
RNS
Collaboration to automate COVID-19 PCR testing
23 Jul 2020 11:06 AM
RNS
Second Price Monitoring Extn
23 Jul 2020 11:00 AM
RNS
Price Monitoring Extension
22 Jul 2020 03:13 PM
RNS
Holding(s) in Company
21 Jul 2020 11:05 AM
RNS
Second Price Monitoring Extn
21 Jul 2020 11:00 AM
RNS
Price Monitoring Extension
16 Jul 2020 04:29 PM
RNS
Holding(s) in Company
13 Jul 2020 09:00 AM
RNS
Price Monitoring Extension
10 Jul 2020 02:05 PM
RNS
Second Price Monitoring Extn
10 Jul 2020 02:00 PM
RNS
Price Monitoring Extension
10 Jul 2020 07:01 AM
RNS
New Genedrive® 96 Exporter software
10 Jul 2020 07:00 AM
RNS
Trading update
01 Jul 2020 07:00 AM
RNS
Total Voting Rights
26 Jun 2020 03:24 PM
RNS
Holding(s) in Company
25 Jun 2020 03:39 PM
RNS
Holding(s) in Company
22 Jun 2020 03:06 PM
RNS
Holding(s) in Company
22 Jun 2020 11:08 AM
RNS
Holding(s) in Company
18 Jun 2020 11:06 AM
RNS
Second Price Monitoring Extn
18 Jun 2020 11:00 AM
RNS
Price Monitoring Extension
17 Jun 2020 04:41 PM
RNS
Second Price Monitoring Extn
17 Jun 2020 04:35 PM
RNS
Price Monitoring Extension
17 Jun 2020 02:05 PM
RNS
Second Price Monitoring Extn
17 Jun 2020 02:00 PM
RNS
Price Monitoring Extension
16 Jun 2020 11:37 AM
RNS
Conversion of Convertible Bond
15 Jun 2020 04:40 PM
RNS
Second Price Monitoring Extn
15 Jun 2020 04:36 PM
RNS
Price Monitoring Extension
10 Jun 2020 07:00 AM
RNS
Investor presentation
09 Jun 2020 04:41 PM
RNS
Second Price Monitoring Extn
09 Jun 2020 04:36 PM
RNS
Price Monitoring Extension
09 Jun 2020 02:06 PM
RNS
Second Price Monitoring Extn
09 Jun 2020 02:00 PM
RNS
Price Monitoring Extension
09 Jun 2020 11:05 AM
RNS
Second Price Monitoring Extn
09 Jun 2020 11:00 AM
RNS
Price Monitoring Extension
29 May 2020 03:02 PM
RNS
Holding(s) in Company
29 May 2020 12:19 PM
RNS
Holding(s) in Company
29 May 2020 11:49 AM
RNS
Holding(s) in Company
29 May 2020 08:30 AM
RNS
Holding(s) in Company
28 May 2020 02:06 PM
RNS
Second Price Monitoring Extn
28 May 2020 02:01 PM
RNS
Price Monitoring Extension
28 May 2020 01:18 PM
RNS
Application for Block Listing
28 May 2020 12:50 PM
RNS
Holding(s) in Company
28 May 2020 11:05 AM
RNS
Second Price Monitoring Extn
28 May 2020 11:00 AM
RNS
Price Monitoring Extension

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings